IRCT138706111166N1已完成2 期
Imiquimod in Combination With Meglumine Antimoniate for Cutaneous Leishmaniasis: A Randomized Assessor-Blind Controlled Trial
the Joint World Health Organization Eastern Mediterranean Region Division of Communicable Diseases0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 60 years（—）
- 性别
- All
入选标准
- •(1) parasitologically proven cases of CL based on positive smear or culture
- •(2) otherwise healthy subjects
- •(3) age 12 to 60 years
- •(4) willingness to participate in the study and sign the informed consent (by the patient or his or her parent or guardian in patients younger than 18 years)
- •Exclusion criteria:
- •(1) pregnant or lactating women,
- •(2) duration of lesions longer than 6 months
- •(3) number of lesions more than 5
- •(4) any lesions larger than 5 cm
- •(5) history of any standard course of treatment with antimonials
- •(6) history of allergy to antimonials
- •(7) serious systemic illnesses (as judged by the physician)
- •(8) participation in any drug trials in the last 60 days.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Comparison of combination of imiquimod and glucantime with glucantime alone in treatment of acute anthroponotic cutaneous leishmaniasisLeishmaniasisAnthroponotic cutaneous leishmaniasisInfections and InfestationsISRCTN77659407World Health Organisation - Eastern Mediterranean Regional Office (EMRO) (Egypt)120
撤回
2 期
Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN: proof of principle.precancerous lesion of the vulvaeVulvar Intraepithelial neoplasia100474381003858810040785NL-OMON33950Erasmus MC, Universitair Medisch Centrum Rotterdam98
进行中（未招募）
不适用
Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN - Effects of HPV-vaccination and imiquimod in VIN patientsIn this trial, the efficacy of Gardasil combined with imiquimod in women with usual type Vulvar Intraepithelial Neoplasia is investigated.MedDRA version: 9.1Level: LLTClassification code 10047778Term: Vulvar cancer in situMedDRA version: 9.1Level: LLTClassification code 10066416Term: Vulvovaginal human papilloma virus infectionMedDRA version: 9.1Level: LLTClassification code 10046859Term: VaccinationMedDRA version: 9.1Level: LLTClassification code 10062059Term: Histology abnormalEUCTR2008-008251-42-NLErasmus MC
已完成
3 期
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous LeishmaniasisCutaneous LeishmaniasisNCT00257530Drugs for Neglected Diseases80
已完成
1 期
Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of MelanomaMelanomaNCT01264731University of Virginia4